Postoperative Tropisetron prevents the transition from acute pain to chronic pain after cesarean section

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900022044

Enrollment

Unknown

Registered

2019-03-21

Start date

2019-01-01

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative the transition from acute pain to chronic pain after cesarean section

Interventions

Group 2:no tropisetron

Group 1:give tropisetron

Eligibility

Sex/Gender

Female

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: After informed, written consents were obtained,pregnant women,ASA physical status I to II, and scheduled for cesarean section were recruited in this study.

Exclusion criteria

Exclusion criteria: Exclusion criteria included: patients with previous heart disease, uncontrolled hypertension, any brain, renal, pulmonary, hepatic disease, and any serious allergy to trial medications, any contraindication to lidocaine, ropivacaine, midazolam, sufentanil, cisatracurium, tropisetron, propofol, diclofenac sodium and any administration of serotonin reuptake inhibitors, and any chronic pain symptom before surgery.

Design outcomes

Primary

Measure	Time frame
Pain Numerical rating scale;self-rating anxiety scale;Edinburgh Postnatal Depression Scale;	—

Secondary

Measure	Time frame
postoperative nausea and vomiting;	—

Countries

China

Contacts

Public ContactGong Xingrui

Shiyan Taihe Hospital, Hubei University of Medicine

gongxrhbxy@sohu.com+86 15926193345

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026